MedPath

Heart Rate Variability in Early Prediction of a Noxic Brain Injury After Cardiac Arrest

Recruiting
Conditions
Cardiac Arrest
Interventions
Device: 24-hour Holter monitoring
Registration Number
NCT06044922
Lead Sponsor
CMC Ambroise Paré
Brief Summary

Despite advances in post-resuscitation care of patients with cardiac arrest (CA), the majority of survivors who are treated after restoration of spontaneous circulation (ROSC) will have sequelae of hypoxic-ischemic brain injury ranging from mild cognitive impairment to a vegetative state.

Early prognostication in comatose patients after ROSC remains challenging. Recent recommendations suggest carrying out clinical and paraclinical tests during the first 72 h after ROSC, to predict a poor neurological outcome with a specificity greater than 95% (no pupillary and corneal reflexes, bilaterally absent N20 somatosensory evoked potential wave, status myoclonus, highly malignant electroencephalography including suppressed background ± periodic discharges or burst-suppression, neuron-specific enolase (NSE) \> 60 µg/L, a diffuse and extensive anoxic injury on brain CT/MRI), but with a low sensitivity due to frequent confounding factors.

The heart rate variability (HRV) is a simple and non-invasive technique for assessing the autonomic nervous system function. In patients with a recent myocardial infarction, reduced HRV is associated with an increased risk for malignant arrhythmias or death. In neurology, reduced HRV is associated with a poor outcome in severe brain injury patients and allows to predict early neurological deterioration and recurrent ischemic stroke after acute ischemic stroke.

A reduced HRV could be a sensitive, specific and early indicator of diffuse anoxic brain injury after CA.

This multicenter prospective cohort study assesses the added value of early HRV (within 24h of ICU admission) for neuroprognostication after cardiac arrest.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Admitted in intensive care unit (ICU) after resuscitation from cardiac arrest (in-hospital or out-of-hospital)
  • Coma (Glasgow score < 8) after ROSC, requiring sedation and targeted temperature management for at least 24h
Exclusion Criteria
  • Dying patient (Limitation of life support techniques at admission to the ICU)
  • Non-Sinus Rhythm
  • Pregnant or breastfeeding women
  • Patient under protection of the adults (guardianship, curators or safeguard of justice)
  • Opposition by the trusted person or by the patient once he/she wakes up

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Post-cardiac arrest patients24-hour Holter monitoring-
Primary Outcome Measures
NameTimeMethod
Poor neurological outcome evaluated using the CPC scoreAt day-28

The CPC (Cerebral Performance Category) score assesses neurological status after cardiac arrest on a scale of 1 to 5 (1 = conscious and normal; 2 = conscious with moderate disability; 3 = conscious with severe disability; 4 = coma or vegetative state; 5 = death).

The CPC score will be dichotomized as follow: good neurological outcome for categories 1 and 2 and poor neurological outcome or death for categories 3, 4 and 5.

The CPC score will be obtained at day-28 from an in-hospital visit if the patient is still hospitalized or by phone call if patient returned home.

Secondary Outcome Measures
NameTimeMethod
Brain deathAt day-28
Net reclassification indexAt day-28
Days without limitation of life sustaining treatmentAt day-28

Trial Locations

Locations (5)

Brest University Hospital

🇫🇷

Brest, Bretagne, France

Ambroise Paré - Hartmann Private Hospital Group

🇫🇷

Neuilly-sur-Seine, Ile-de-France, France

Cochin Hospital

🇫🇷

Paris, Ile-de-France, France

Nantes University Hospital

🇫🇷

Nantes, Pays de la Loire, France

Marseille University Hospital

🇫🇷

Marseille, Provence-Alpes-Côte d'Azur, France

© Copyright 2025. All Rights Reserved by MedPath